The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Related Posts
SpaceX lines up four Wall Street banks for mega 2026 IPO, source says
Jan 22 (Reuters) – Elon Musk’s space startup SpaceX is lining up four Wall Street banks for leading roles on…
Nvidia’s strong forecast calms AI bubble jitters – for now
By Arsheeya Bajwa and Stephen Nellis (Reuters) -Nvidia forecast quarterly revenue well above Wall Street estimates on Wednesday and CEO…
Active Dynamics buys First Brands’ Walbro business for $50 million
By Dietrich Knauth NEW YORK, March 10 (Reuters) – Bankrupt U.S. auto parts maker First Brands said Tuesday that it…